norgestrel and Thromboembolism

norgestrel has been researched along with Thromboembolism in 27 studies

Research

Studies (27)

Timeframe	Studies, this research(%)	All Research%
pre-1990	11 (40.74)	18.7374
1990's	7 (25.93)	18.2507
2000's	6 (22.22)	29.6817
2010's	3 (11.11)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abe, J; Fukuda, A; Hane, Y; Hasegawa, S; Hatahira, H; Hirade, K; Kinosada, Y; Matsui, T; Motooka, Y; Naganuma, M; Nakamura, M; Sasaoka, S; Takahashi, Y	1
Curtis, KM; Dragoman, MV; Gaffield, ME; Tepper, NK	1
Cheetham, TC; Connell, FA; Cooper, WO; Davis, D; Graham, DJ; Ouellet-Hellstrom, R; Quesenberry, CP; Sidney, S; Sorel, M	1
Dabholkar, NA; Rane, VA	1
Jick, H; Jick, SS; Kaye, JA; Russmann, S	2
Brenner, P	1
Cole, JA; Doherty, M; Norman, H; Walker, AM	1
Jick, H; Jick, S; Kaye, JA; Li, L	1
Brenner, PF; de Quattro, V; Dozono-Takano, R; Eide, I; Gray, G; Mishell, DR; Roy, S; Shaw, ST	1
Jespersen, J; Kluft, C	1
Donnelly, RJ	1
Amiral, J; Guize, L; Plu-Bureau, G; Scarabin, PY	1
Bruppacher, R; Heinemann, LA; Lewis, MA; MacRae, KD; Spitzer, WO	1
Handler, S; Huber, J; Kapiotis, S; Loner, U; Quehenberger, P; Schneider, B; Speiser, W	1
Lidegaard, O	1
Danzinger, RG; Koh, KS	1
Heil, CG; Korba, VD	1
Kapu, MM; Mwaigwe, MM; Temple, VJ; Wright, EA	1
Ratnam, SS; Singh, K; Viegas, OA	1
Bonnar, J; Sabra, AM	1
Bonnar, J	1
Avery, GS; Brogden, RN; Speight, TM	1
Villedieu, P	1

Reviews

2 review(s) available for norgestrel and Thromboembolism

Article	Year
Nonoral combined hormonal contraceptives and thromboembolism: a systematic review. Contraception, 2017, Volume: 95, Issue:2 Topics: Administration, Cutaneous; Adolescent; Adult; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Estrogens; Female; Humans; Levonorgestrel; Norgestrel; Progestins; Risk Factors; Thromboembolism; Venous Thromboembolism; Young Adult	2017
Progestagen-only oral contraceptives: a preliminary report of the action and clinical use of norgestrel and norethisterone. Drugs, 1973, Volume: 6, Issue:3 Topics: Breast Neoplasms; Chlormadinone Acetate; Contraceptives, Oral; Corpus Luteum; Dose-Response Relationship, Drug; Female; Fertility; Follicle Stimulating Hormone; Humans; Lipids; Lipoproteins; Luteinizing Hormone; Mucus; Norethindrone; Norgestrel; Pregnancy; Thromboembolism; Vaginal Neoplasms	1973

Article

Year

Nonoral combined hormonal contraceptives and thromboembolism: a systematic review.

Contraception, 2017, Volume: 95, Issue:2

Topics: Administration, Cutaneous; Adolescent; Adult; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Estrogens; Female; Humans; Levonorgestrel; Norgestrel; Progestins; Risk Factors; Thromboembolism; Venous Thromboembolism; Young Adult

2017

Progestagen-only oral contraceptives: a preliminary report of the action and clinical use of norgestrel and norethisterone.

Drugs, 1973, Volume: 6, Issue:3

Topics: Breast Neoplasms; Chlormadinone Acetate; Contraceptives, Oral; Corpus Luteum; Dose-Response Relationship, Drug; Female; Fertility; Follicle Stimulating Hormone; Humans; Lipids; Lipoproteins; Luteinizing Hormone; Mucus; Norethindrone; Norgestrel; Pregnancy; Thromboembolism; Vaginal Neoplasms

1973

Trials

2 trial(s) available for norgestrel and Thromboembolism

Article	Year
Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring. American journal of obstetrics and gynecology, 1980, Apr-01, Volume: 136, Issue:7 Topics: Adolescent; Adult; Alkaline Phosphatase; Angiotensin II; Antithrombin III; Aspartate Aminotransferases; Bilirubin; Cholesterol; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Levonorgestrel; Mestranol; Norethindrone; Norgestrel; Thromboembolism; Transcortin; Triglycerides	1980
Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives. Thrombosis and haemostasis, 1996, Volume: 76, Issue:5 Topics: Adult; Blood Coagulation; Blood Proteins; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Factor VIIa; Female; Humans; Norgestrel; Norpregnenes; Prospective Studies; Protein S; Risk Factors; Thromboembolism; Thrombomodulin	1996

Article

Year

Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.

American journal of obstetrics and gynecology, 1980, Apr-01, Volume: 136, Issue:7

Topics: Adolescent; Adult; Alkaline Phosphatase; Angiotensin II; Antithrombin III; Aspartate Aminotransferases; Bilirubin; Cholesterol; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Levonorgestrel; Mestranol; Norethindrone; Norgestrel; Thromboembolism; Transcortin; Triglycerides

1980

Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.

Thrombosis and haemostasis, 1996, Volume: 76, Issue:5

Topics: Adult; Blood Coagulation; Blood Proteins; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Factor VIIa; Female; Humans; Norgestrel; Norpregnenes; Prospective Studies; Protein S; Risk Factors; Thromboembolism; Thrombomodulin

1996

Other Studies

23 other study(ies) available for norgestrel and Thromboembolism

Article	Year
Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database. PloS one, 2017, Volume: 12, Issue:7 Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Androstenes; Child; Contraceptives, Oral, Combined; Databases, Factual; Desogestrel; Drug-Related Side Effects and Adverse Reactions; Estrogens; Ethinyl Estradiol; Female; Humans; Japan; Levonorgestrel; Male; Middle Aged; Norethindrone; Norgestrel; Odds Ratio; Progestins; Thromboembolism; Young Adult	2017
Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users. Contraception, 2013, Volume: 87, Issue:1 Topics: Adolescent; Adult; Androstenes; Arteries; California; Child; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Hospitalization; Humans; Incidence; Middle Aged; Myocardial Infarction; Norgestrel; Proportional Hazards Models; Risk Factors; Stroke; Tennessee; Thromboembolism; Time Factors; Venous Thromboembolism; Washington; Young Adult	2013
Sixth fertility and sterility congress--a review. IPPF medical bulletin, 1968, Volume: 2, Issue:3 Topics: Biology; Chlormadinone Acetate; Clomiphene; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Copper; Disease; Embolism; Endocrine System; Estrogens; Evaluation Studies as Topic; Family Planning Services; Hormones; Incidence; Infections; Injections; Intrauterine Devices; Medroxyprogesterone Acetate; Menstruation Disturbances; Norgestrel; Pelvic Inflammatory Disease; Physiology; Progesterone Congeners; Quinestrol; Research; Research Design; Therapeutics; Thromboembolism; Time; Uterine Perforation; Vascular Diseases; Zinc	1968
Effect of short term use of oral contraceptives on fibrinolytic activity of the blood. Current medical practice, 1973, Volume: 17, Issue:5 Topics: Biology; Blood; Blood Coagulation; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Disease; Embolism; Ethinyl Estradiol; Family Planning Services; Fibrinolysis; Norgestrel; Physiology; Research; Thromboembolism; Thrombosis; Vascular Diseases	1973
Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol. Contraception, 2006, Volume: 73, Issue:3 Topics: Administration, Cutaneous; Adolescent; Adult; Case-Control Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Humans; Norgestrel; Risk Factors; Thromboembolism	2006
Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel. Contraception, 2006, Volume: 73, Issue:6 Topics: Adolescent; Adult; Case-Control Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Databases, Factual; Desogestrel; Female; Humans; Levonorgestrel; Longitudinal Studies; Norgestrel; Odds Ratio; Risk Factors; Thromboembolism	2006
Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol. Contraception, 2006, Volume: 74, Issue:4 Topics: Administration, Cutaneous; Adolescent; Adult; Contraceptive Agents; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Longitudinal Studies; Norgestrel; Pregnancy; Risk; Thromboembolism	2006
Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users. Obstetrics and gynecology, 2007, Volume: 109, Issue:2 Pt 1 Topics: Administration, Cutaneous; Brain Ischemia; Case-Control Studies; Cohort Studies; Contraceptives, Oral; Drug Combinations; Ethinyl Estradiol; Female; Humans; Incidence; Myocardial Infarction; Norgestrel; Stroke; Thromboembolism; Venous Thrombosis	2007
Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol. Contraception, 2007, Volume: 76, Issue:1 Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Case-Control Studies; Contraceptive Agents, Female; Databases, Factual; Ethinyl Estradiol; Female; Humans; Managed Care Programs; Norgestrel; Risk Factors; Thromboembolism; United States	2007
Evra contraceptive patch: risks of thromboembolism. Prescrire international, 2007, Volume: 16, Issue:89 Topics: Administration, Cutaneous; Canada; Contraceptive Agents, Female; Dose-Response Relationship, Drug; Ethinyl Estradiol; Europe; Female; Humans; Norgestrel; Risk; Thromboembolism; United States; Women's Health	2007
Decreased levels of histidine-rich glycoprotein (HRG) and increased levels of free plasminogen in women on oral contraceptives low in estrogen. Thrombosis and haemostasis, 1982, Dec-27, Volume: 48, Issue:3 Topics: Adult; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Glycoproteins; Humans; Norgestrel; Plasminogen; Proteins; Thromboembolism	1982
Third generation oral contraceptives. Study's results do not apply to norgestimate. BMJ (Clinical research ed.), 1996, Mar-02, Volume: 312, Issue:7030 Topics: Contraceptives, Oral, Synthetic; Female; Humans; Norgestrel; Thromboembolism	1996
Safety of combined oral contraceptive pills. Lancet (London, England), 1996, Feb-24, Volume: 347, Issue:9000 Topics: Adult; Blood Coagulation Factors; Contraceptives, Oral, Combined; Cross-Sectional Studies; Desogestrel; Female; Fibrinolysis; Humans; Lipids; Middle Aged; Norgestrel; Norpregnenes; Progesterone Congeners; Thromboembolism	1996
The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women. Contraception, 1996, Volume: 54, Issue:1 Topics: Adolescent; Adult; Bias; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Odds Ratio; Progesterone Congeners; Risk Factors; Thromboembolism	1996
The influence of thrombotic risk factors when oral contraceptives are prescribed. A control-only study. Acta obstetricia et gynecologica Scandinavica, 1997, Volume: 76, Issue:3 Topics: Adolescent; Adult; Body Mass Index; Case-Control Studies; Causality; Contraceptives, Oral; Denmark; Desogestrel; Dose-Response Relationship, Drug; Female; Humans; Levonorgestrel; Migraine Disorders; Multivariate Analysis; Norgestrel; Norpregnenes; Risk Factors; Smoking; Socioeconomic Factors; Thromboembolism	1997
Massive intestinal infarction in young women: complication of use of oral contraceptives? Canadian Medical Association journal, 1977, Mar-05, Volume: 116, Issue:5 Topics: Abdomen, Acute; Adult; Arteriosclerosis; Celiac Artery; Contraceptives, Oral; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Humans; Iliac Artery; Infarction; Intestines; Lynestrenol; Mesenteric Vascular Occlusion; Mestranol; Norethindrone; Norethynodrel; Norgestrel; Smoking; Thromboembolism; Time Factors	1977
Letter: Side effects of oral contraceptives. The Medical journal of Australia, 1975, Mar-08, Volume: 1, Issue:10 Topics: Contraceptives, Oral; Estrogens; Female; Humans; Infertility, Female; Libido; Norgestrel; Pregnancy; Thromboembolism; Thrombosis	1975
Eight years of fertility control with norgestrel-ethinyl estradiol (Ovral): an updated clinical review. Fertility and sterility, 1975, Volume: 26, Issue:10 Topics: Adrenal Glands; Adult; Breast Neoplasms; Cervix Uteri; Contraception; Drug Evaluation; Ethinyl Estradiol; Eye; Female; Fertility; Follow-Up Studies; Humans; Infant, Newborn; Liver; Maternal-Fetal Exchange; Menstruation; Menstruation Disturbances; Norgestrel; Pregnancy; Thromboembolism; Thyroid Gland	1975
Globulines anormalment precipitables (GAP) in Nigerian users of progestogen-only pill. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1990, Volume: 31, Issue:2 Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Female; Humans; Immunoglobulin G; Intrauterine Devices; Male; Nigeria; Norgestrel; Thromboembolism	1990
A three-year evaluation of hemostatic function in Singaporean Norplant-2 rod acceptors. Advances in contraception : the official journal of the Society for the Advancement of Contraception, 1990, Volume: 6, Issue:2 Topics: Contraceptive Agents, Female; Drug Implants; Female; Hemostasis; Humans; Levonorgestrel; Longitudinal Studies; Norgestrel; Partial Thromboplastin Time; Prothrombin Time; Singapore; Thromboembolism	1990
Oral contraceptives and blood coagulation. The Journal of reproductive medicine, 1986, Volume: 31, Issue:6 Suppl Topics: Age Factors; Antithrombin III; Blood Coagulation; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Factor VII; Factor X; Female; Fibrinolysis; Humans; Norgestrel; Norpregnenes; Platelet Aggregation; Prothrombin; Thromboembolism	1986
Coagulation effects of oral contraception. American journal of obstetrics and gynecology, 1987, Volume: 157, Issue:4 Pt 2 Topics: Blood Coagulation; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Fibrinolysis; Humans; Levonorgestrel; Mestranol; Norethindrone; Norethindrone Acetate; Norgestrel; Norpregnenes; Platelet Aggregation; Risk Factors; Thromboembolism; Thrombosis	1987
[Clinical study of an estro-progestative association in low doses. Experience of 3 years (490 patients-5600 cycles)]. Lyon medical, 1972, May-14, Volume: 227, Issue:9 Topics: Acne Vulgaris; Body Weight; Contraceptives, Oral; Digestive System; Drug Combinations; Drug Tolerance; Endometriosis; Ethinyl Estradiol; Female; Humans; Hypertension; Menstruation Disturbances; Migraine Disorders; Norgestrel; Thromboembolism	1972